Semaglutide Patents

Given below is the list of patents protecting Semaglutide, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Semaglutide's patents.

Latest Legal Activities on Semaglutide's Patents

Given below is the list recent legal activities going on the following patents of Semaglutide.

Activity	Date	Patent Number
Critical Events This Week
Payment of Maintenance Fee, 4th Year, Large Entity	18 Dec, 2025	US11382957
Payment of Maintenance Fee, 4th Year, Large Entity	23 Oct, 2025	US11318191(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity	20 Feb, 2025	US9764003(Litigated)
Payment of Maintenance Fee, 4th Year, Large Entity	20 Aug, 2024	US10933120
Payment of Maintenance Fee, 4th Year, Large Entity	20 Aug, 2024	US10960052
Payment of Maintenance Fee, 4th Year, Large Entity	20 Jun, 2024	US10888605(Litigated)
Email Notification Critical	20 Sep, 2023	US11759503
Email Notification Critical	20 Sep, 2023	US11759501
Email Notification Critical	20 Sep, 2023	US11759502
Patent eGrant Notification	19 Sep, 2023	US11759501